Viridian Therapeutics, Inc.DE

WALTHAM, MA How do I update this listing?

Create Email Alert

Viridian Therapeutics, Inc.de is based out of Waltham. Miragen Therapeutics, Inc. operates as a biopharmaceutical company. The Company develops microRNA biology, oligonucleotide chemistry, drugs, and therapies for cancer, pathologic fibrosis, neuro-inflammatory, and cardiovascular diseases. Miragen Therapeutics serves customers in the United States. Whalewisdom has at least 67 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2020-11-06. The notice included securities offered of Equity

Contact Info

viridian therapeutics, inc.de
203 CRESCENT STREET
WALTHAM MA    02453

Business Phone: 617.272.4600
SEC SIC CODE:
8071-SERVICES-MEDICAL LABORATORIES

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2020-11-06 D BIOTECHNOLOGY Equity 90,997,328 90,997,328 0
2019-10-31 D/A BIOTECHNOLOGY Equity 5,000,000 1,500,000 3,500,000
2018-08-06 D BIOTECHNOLOGY Equity 5,000,000 1,000,000 4,000,000
2017-11-22 D BIOTECHNOLOGY Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 172,294 172,294 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
WILLIAM S. MARSHALL subscription required
    EXECUTIVE OFFICER DIRECTOR
JASON A. LEVERONE subscription required
    EXECUTIVE OFFICER
ADAM S. LEVY subscription required
    EXECUTIVE OFFICER
PAUL D. RUBIN subscription required
    EXECUTIVE OFFICER
BRUCE L. BOOTH subscription required
    DIRECTOR
CHRISTOPHER BOWDEN subscription required
    DIRECTOR
JEFFREY S. HATFIELD subscription required
    DIRECTOR
THOMAS E. HUGHES subscription required
    DIRECTOR
KEVIN KOCH subscription required
    DIRECTOR
JOSEPH L. TUNER subscription required
    DIRECTOR
ARLENE M. MORRIS subscription required
    DIRECTOR
JOSEPH L. TURNER subscription required
    DIRECTOR
JONATHAN VIOLIN subscription required
    EXECUTIVE OFFICER
LEE M RAUCH subscription required
    EXECUTIVE OFFICER DIRECTOR
DIANA ESCOLAR subscription required
    EXECUTIVE OFFICER
PETER E. HARWIN subscription required
    DIRECTOR
TOMAS KISELAK subscription required
    DIRECTOR
JOESPH L. TURNER subscription required
    DIRECTOR

Elevate your investments